About Conference

We extend our warmest greetings and heartfelt welcome to the 33rd International Conference on Clinical Diabetes, Diabetic Medication & Treatment! It is our immense pleasure to host this prestigious event in the enchanting city of Paris, France, from November 26-27, 2024.

As the organizing committee, we have curated an exceptional scientific program that encompasses the latest advancements in diabetes research, innovative treatment approaches, and emerging therapies. This conference serves as an invaluable platform for knowledge exchange, networking, and fostering collaborations among leading experts, healthcare professionals, and researchers.

Join us in the captivating city of Paris, renowned for its rich history, breath-taking architecture, and gastronomic delights. We are confident that the conference will be an enlightening and memorable experience, combining academic excellence with cultural immersion.

Why to Attend

Diabetes Conference 2024 offers an opportunity to network with researchers, and as a result, it takes pleasure in providing attendees with a first-look at cutting-edge methodologies, approaches, and the most recent developments in the field of diabetes. The usual sessions to be examined in this diabetes meeting include recent developments in endocrinology and assimilation, diabetes genetic characteristics, clinical diabetes, diabetic problems, diabetes prescriptions and pharmacology, and cell treatment for diabetes. One of the illnesses that are on the rise and getting really serious these days is diabetes. In order to be innovative, the social gathering will be based on the most recent and exciting developments in each component of Diabetes gatherings. We are considering providing a fantastic open portal for all researchers to gather, organise, and manage fresh real movements.

Scope

New insulin analogues, new technology, and diabetes-related equipment will all be covered at the Diabetes Conference 2024, along with the most recent advancements in diabetes research, diagnosis, and prevention.

The Editors will focus on studies that include carefully chosen findings that establish a connection between basic research and translation to disorders connected to diabetes. The editors support the dissemination of original answers to difficult scientific and translational problems connected to research on diabetes and illnesses that are related to metabolism or genetics.

It is expected that authors of JDRT articles will come from a variety of scientific fields with a focus on diabetes as well as various experts who study glucose metabolic homeostasis and related topics. These research would most likely concentrate on risk factors for disease and the pathophysiology of conditions linked to disorders of glucose metabolic dysregulation.

List of Diabetes Universities Worldwide

• Monash University Malaysia
• International Medical University
• Asia Pacific University of Technology and Innovation
• Albert Einstein-Mount Sinai Diabetes Center
• Columbia University
• Indiana Diabetes Research Center 
• Joslin Diabetes Center-Harvard Medical School
• Stanford Diabetes Research Center
• The University of Chicago Diabetes Research 
• Washington University at St. Louis
• Kaiser Foundation Research Institute, California San Francisco
• University of Cambridge
• Johns Hopkins University
• Yale University
• University of California, Los Angeles (UCLA)
• Imperial College London
• University of Melbourne
• Karolinska Institute

Diabetic drugs:

The 50+ diabetes drugs are available in the world in the form of tablets or injection suspension and placed into different drug classes.

• Insulin
• Biguanides / Metformin
• Sulphonylureas
• Meglitinides / Prandial glucose regulator / Glinides
• Alpha-glucosidase inhibitors
• Thiazolidinedione / Glitazones
• DPP-4 inhibitors / Gliptins
• Incretin mimetics / GLP-1 analogues
• Amylin analogues

Participation Options and Benefits

Diabetic studies, provides the participants with different modes or ways to participate  as Delegate or Speaker under either ACADEMIC / STUDENT / BUSINESS Category. 

• Keynote speaker: 45-50 minutes
• Speaker (oral presentation): 25-30 minutes (only one person can present)
• Speaker (workshop): 45-50 minutes (more than 1 can present)
• Speaker (special session): 45-50 minutes (more than 1 can present)
• Speaker (symposium): more than 45 minutes (more than 1 can present)
• Delegate(only registration): will have access to all the sessions with all the benefits of registration
• Poster presenter:  can present a poster and enjoy the benefits of delegate
• Remote attendance:  can participate via video presentation or e-poster presentation
• Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes
• Media partner
• Sponsor
• Collaborator

PARTICIPATION BENEFITS:

• Attend Keynote Presentation by world’s most eminent researchers
• Access to all the sessions
• Get worldwide acknowledgment to your profile and Research
• Get your abstracts published with unique DOI in International Journals
• Get up to 50% discounts for publishing your entire article in our open access International Journals
• Get Handbooks and conference kits
• Get an access to the network with eminent personalities from worldwide
• To learn and expand the knowledge from Top immunologists, Professionals
• Get your Abstract published and Certified for your participation
• Mark new links and trigger  your profession
• Acquire a global exposure to your research idea

Session Tracks

Session 1: Diabetes and Endocrinology

Focusing on the investigation, diagnosis, and treatment of endocrine system problems is the field of endocrinology and diabetes. Thilood sugar control are all greatly improved by endocrinologists. Technologies for glucose monitoring and treatment covers ailments like diabetes, thyroid, adrenal, and other illnesses. A patient's overall health, hormonal balance, and BT methods are being improved as a result of ongoing research and breakthroughs in the sector. Healthcare workers, researchers, and business leaders can collaborate and share knowledge at conferences on diabetes and endocrinology to improve patient care.

Session 2: Diabetes and Obesity

Obesity and diabetes are closely related. Due to altered glucose metabolism and insulin resistance, obesity raises the risk of type 2 diabetes. Extra body fat, especially in the abdominal area, has a role in hormonal imbalances and chronic inflammation that affect insulin function. On the other hand, diabetes itself can cause weight gain and make it difficult to regulate weight. A comprehensive strategy is needed to manage both disorders, including lifestyle changes including healthy eating, regular exercise, weight loss, and, where required, pharmaceutical management to regulate blood sugar levels and encourage weight loss.

Session 3: Global Market for Diabetes and its Research

The global market for research on diabetes is growing quickly. The demand for novel medicines, diagnostic tools, and monitoring technologies is increasing as diabetes prevalence rises globally. Pharmaceuticals, insulin administration methods, glucose monitoring tools, and research services are all included in the market. New therapy alternatives are also being developed as a result of developments in stem cell research, precision medicine, and artificial intelligence. Significant potential exist in the market for businesses and researchers to contribute to the constantly changing field of diabetes care.

Session 4: Cardiovascular risk in Type 2 Diabetes

Cardiovascular problems are related with a higher incidence of type 2 diabetes. The syndrome frequently coexists with a number of risk factors that advance atherosclerosis and cardiovascular disease, including obesity, hypertension, dyslipidaemia, and insulin resistance. Changes in lifestyle, glycaemic control, blood pressure management, lipid management, and antiplatelet therapy are all part of managing cardiovascular risk in type 2 diabetes. To lessen the burden of cardiovascular disease in patients with type 2 diabetes, a thorough cardiovascular risk assessment and individualised treatment plans are necessary.

Session 5: Advanced technologies for the treatment of diabetes

For the treatment of diabetes, several cutting-edge technologies have been developed. In order to improve glucose control and lower the risk of complications, continuous glucose monitoring (CGM) systems deliver real-time glucose readings. Automated artificial pancreas devices automate insulin delivery based on CGM data, simulating a healthy pancreas's function. Insulin dose can be customised thanks to closed-loop systems that combine CGM and insulin pumps. By replacing damaged insulin-producing cells, islet cell transplantation offers a potential treatment for type 1 diabetes. Long-term answers may be found through gene therapy and stem cell research. These cutting-edge devices are meant to help people with diabetes better control their condition and live better overall.

Session 6: Gestational Diabetes

A condition known as gestational diabetes occurs when high blood sugar levels rise during pregnancy. It is frequently discovered between weeks 24 and 28 of pregnancy and is brought on by hormonal changes that influence both the synthesis and usage of insulin. The disease increases the risk of type 2 diabetes later in life as well as problems during childbirth for both the mother and the unborn child. In order to maintain ideal blood glucose levels and guarantee a successful pregnancy, managing gestational diabetes frequently needs a mix of blood sugar monitoring, dietary adjustments, regular physical activity, and occasionally insulin therapy.

Session 7: Diabetes Ophthalmology

Diabetes ophthalmology is concerned with diabetes's consequences that affect the eyes, particularly diabetic retinopathy and diabetic macular edoema. Diabetes can harm the blood vessels in the retina, which could result in vision loss if ignored. This condition is known as diabetic retinopathy. The term "diabetic macular edoema" refers to swelling of the macula, a tiny but significant portion of the retina that controls central vision. Surgical vitrectomy, intravitreal injections of VEGF inhibitors, and laser photocoagulation are among the available treatments. For controlling and avoiding diabetes-related visual issues, routine eye exams and early identification are essential.

Session 8: Reproductive Endocrinology

The hormonal and reproductive health of both men and women is the focus of the medical specialty known as reproductive endocrinology. It includes the identification and management of a wide range of hormonal and reproductive problems. Specialised in helping people or couples who are having trouble getting pregnant, reproductive endocrinologists treat conditions like infertility, polycystic ovarian syndrome (PCOS), endometriosis, and hormonal imbalances. In order to help people reach their reproductive goals, treatment options may include fertility drugs, assisted reproductive technologies (such in vitro fertilisation), hormone therapy, surgical interventions, and counselling.

Session 9: Endocrine Glands and Hormones

The body's endocrine system is made up of multiple glands that generate and release hormones, which are chemical messengers that control a variety of bodily activities. The pituitary gland, thyroid, adrenal, pancreatic, ovarian, and testicular endocrine glands are among the major endocrine organs. Hormones such growth hormone, thyroid hormones, cortisol, insulin, oestrogen, and testosterone are all secreted by these glands. Hormones are vital for metabolism, growth and development, reproduction, stress management, and maintaining overall homeostasis. Disorders like diabetes, hypothyroidism, hyperthyroidism, and hormonal abnormalities that impair fertility and sexual function can all be caused by imbalances in hormone production or function.

Session 10: Diabetes and Periodontitis

Periodontitis (gum disease) and diabetes are linked in both directions. Diabetes impairs immune response and slows wound healing, making people more vulnerable to periodontitis. Conversely, periodontitis can impair the management of diabetes by raising blood sugar levels and insulin resistance. Effective diabetes and periodontitis control, consistent dental check-ups, and good oral hygiene are essential. For people with diabetes, lowering blood sugar levels and treating periodontitis can reduce risks and enhance overall health outcomes.

Session 11: Diabetes Advanced Technologies

Modern technology have completely changed how diabetes is managed. Real-time glucose readings are provided by continuous glucose monitoring (CGM) systems, improving glucose control and minimising problems. Compared to regular injections, insulin pumps offer greater flexibility and convenience by delivering precise insulin doses. Personalised and ideal glucose control are provided by closed-loop systems, also referred to as artificial pancreas systems, which automate insulin delivery based on CGM data. Alternative insulin delivery techniques include inhalable insulin and smart insulin pens. Additionally, remote monitoring, data analysis, and virtual consultations are made possible via telemedicine and smartphone applications, which expands access to diabetes care. With the help of these cutting-edge technology, people with diabetes can improve their quality of life, achieve better glycaemic control, and lessen the burden of managing their condition.

Session 12: Diabetes Research in Clinical Practice

Clinical practise is significantly influenced by diabetes research. It aids in the discovery of novel therapeutic approaches, diagnostic devices, and preventative measures. Evidence-based information on the efficacy and safety of novel therapies is provided via clinical studies. Research focuses on areas such new pharmacological targets, regenerative therapeutics, artificial intelligence, and personalised medicine. Research study findings assist healthcare workers in making knowledgeable choices regarding the management of diabetes. Advancements in diabetes research help to improve patient outcomes, enhance care delivery, and eventually strive towards better diabetes prevention and treatment by bridging the gap between research and clinical practise.

Session 13: Stem Cell treatment in Diabetes

Diabetes management may benefit from stem cell therapy. In order to replace damaged or defective cells in diabetic patients, researchers are investigating the capacity of stem cells to develop into cells that produce insulin. The regenerative potential of many stem cell types, such as adult stem cells, induced pluripotent stem cells, and embryonic stem cells, is being investigated. Early clinical trials have produced good outcomes in terms of enhancing insulin production and glycaemic management. Before stem cell-based therapies for diabetes may be extensively used in clinical practise, additional study is required to confirm their safety, long-term efficacy, and scalability.

Session 14: Thyroid Disorders in Children, Teens and Adolescents

Children, teenagers, and adolescents are susceptible to thyroid abnormalities, which can cause a number of health problems. Fatigue, weight gain, and poor growth are all possible effects of hypothyroidism, which is characterised by an underactive thyroid. Weight loss, anger, and rapid development can be brought on by hyperthyroidism, an overactive thyroid. Although they are rather uncommon in this age group, thyroid nodules and thyroid cancer are also possible. Blood tests, imaging scans, and occasionally biopsies are used to diagnose thyroid abnormalities in young people. Depending on the particular illness and how severe it is, possible treatments include medication, surgery, or radioactive iodine therapy.

Session 15: Insulin Medication

The most important drug used to treat diabetes is insulin. People with type 1 diabetes, as well as some cases of type 2 diabetes, are typically prescribed it. By stimulating the uptake of glucose into cells for use as fuel, insulin is in charge of controlling blood sugar levels. Although insulin pumps are also available, it is mainly supplied by injection. Taking into account things like meal times, exercise levels, and blood sugar monitoring, the dosage and timing of insulin delivery are tailored based on a person's unique needs. Aiming to maintain ideal blood sugar management, prevent diabetes-related problems, and advance general health and wellbeing. To achieve optimal treatment, regular monitoring and modifications are required.

Session 16: Treatment and Diagnosis of Endocrine Diseases

Endocrine disorder diagnosis and treatment require a thorough approach. The evaluation of hormone levels, physical exams, blood tests, imaging studies, and reviews of medical histories are frequently part of the diagnosis process. Depending on the issue, different treatment plans may be used, including hormone replacement therapy, medicines, lifestyle changes, or surgical procedures. To determine the effectiveness of the treatment and make any required adjustments, careful observation and frequent follow-up are crucial. Endocrinologists, family doctors, and other experts who practise multidisciplinary treatment guarantee a thorough and individualised approach to addressing endocrine illnesses and maximising patient outcomes.

Session 17: Ketogenic Diet for Diabetes

The ketogenic diet, which is high in fat and low in carbohydrates, has drawn interest as a potential treatment strategy for the management of diabetes. The goal of the ketogenic diet is to induce a state of ketosis, in which the body uses ketones as its primary fuel source rather than glucose. This state is achieved by severely limiting carbohydrate intake. According to certain research, type 2 diabetics who follow a ketogenic diet may see an increase in insulin sensitivity and better blood sugar regulation. However, as this diet's long-term effects and safety in managing diabetes are still being studied, caution should be taken as it may not be suitable for everyone. Before making any dietary adjustments, you must speak with a medical expert.

Session 18: Diabetic Disorders and Treatment

Diabetic disorders encompass a range of conditions associated with diabetes, including type 1 diabetes, type 2 diabetes, and gestational diabetes. Effective treatment involves a multi-faceted approach. It includes lifestyle modifications such as adopting a healthy diet and regular exercise, along with medication management. Medications may include oral antidiabetic drugs, insulin therapy, or a combination of both. Close monitoring of blood glucose levels, regular medical check-ups, and preventive measures to manage complications like neuropathy, retinopathy, and nephropathy are vital for comprehensive diabetic disorder management.

Session 19: Natural therapy for Diabetes

Natural remedies can be used in conjunction with traditional medical care to manage diabetes, but they shouldn't take the place of it. Following are some examples of natural treatments for diabetes management:

• Herbal remedies: Some plants, including fenugreek, bitter melon, and cinnamon, may help control blood sugar levels.
• Mind-body practises: Exercises like yoga, meditation, and acupuncture may help people reduce stress and increase their bodies' ability to use insulin.
• Changes in nutrition: Whole grains, vegetables, lean proteins, and healthy fats are all components of a nutritious diet that can help regulate blood sugar.

It's critical to maintain receiving regular medical care for diabetes management and to seek advice from a healthcare expert before implementing any alternative remedies.

Session 20: COVID-19 Impacts People with Diabetes

If COVID-19 is contracted, those who have diabetes are more likely to suffer serious consequences. The risk of diabetic ketoacidosis or hyperglycaemia can increase as a result of the virus making blood sugar levels harder to control. As a result of their weakened immune systems, people with diabetes are also more prone to infections. To lessen the chance of COVID-19 problems, it is essential for patients with diabetes to follow preventive practises such glycaemic control, social isolation, mask use, excellent hand hygiene, and wearing protective clothing. Diabetes must be managed during this time with regular communication with healthcare professionals.

Market Analysis

The 33rd International Conference on Clinical Diabetes, Diabetic Medication & Treatment, scheduled to be held on November 26-27, 2024, in Paris, France, presents a significant market opportunity within the field of diabetes research, medication, and treatment.

The global market for diabetes and related products and services has been experiencing substantial growth in recent years. The rising prevalence of diabetes, coupled with increased awareness and advancements in medical technology, has fueled the demand for innovative solutions and effective treatment modalities.

The conference provides a platform for researchers, healthcare professionals, and industry experts to showcase the latest scientific advancements, clinical trials, and emerging technologies in the field of diabetes. This offers an excellent opportunity for participants to explore cutting-edge products, therapies, and diagnostic tools presented by leading companies and research organizations.

The conference also serves as a hub for networking and collaboration, allowing attendees to forge strategic partnerships and explore potential business opportunities. Pharmaceutical companies, medical device manufacturers, biotechnology firms, and healthcare service providers can benefit from exposure to a highly targeted audience of key opinion leaders, clinicians, and researchers in the diabetes field.

Furthermore, the conference facilitates knowledge exchange and professional development through keynote lectures, panel discussions, and interactive sessions. It offers a platform for participants to enhance their understanding of current trends, challenges, and best practices in clinical diabetes management, medication, and treatment.

With its location in the vibrant city of Paris, the conference is poised to attract a diverse and international audience. The city's rich cultural heritage, world-class healthcare infrastructure, and renowned research institutions further contribute to the overall appeal and market potential of the event.

In conclusion, the 33rd International Conference on Clinical Diabetes, Diabetic Medication & Treatment presents a significant market opportunity for stakeholders in the diabetes research, medication, and treatment industry. It offers a unique platform for knowledge exchange, networking, and business development, fostering innovation and advancements in the field of diabetes care.